BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Finance Desk//Catalysts//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Finance Desk catalysts
X-PUBLISHED-TTL:PT1H
REFRESH-INTERVAL;VALUE=DURATION:PT1H
BEGIN:VEVENT
UID:fd-catalyst-2554@financedesk
DTSTAMP:20261014T045622Z
DTSTART;VALUE=DATE:20270202
SUMMARY:FDA action date for once-weekly oral Yeztugo (lenacapavir) for HIV
  prevention
DESCRIPTION:Confirmed date.\nGilead Sciences\, Yeztugo (lenacapavir)\, GIL
 D\nhttps://wiremeridian.com/c/gilead
URL:https://wiremeridian.com/c/gilead
STATUS:CONFIRMED
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR